InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Killeen Matthew, Responsable scientifique. Insider active across 1 company, notably Renovacor, Inc.. Aggregated, 2 reports have been published. Activity tracked since 24 January 2022. The latest transaction was filed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Matthew Killeen serves as Chief Scientific Officer of Renovacor, Inc. In this role, he oversees the company's research and development activities, contributing to innovation in the field of gene therapies. Renovacor, Inc. is a biopharmaceutical company specializing in developing treatments for heart diseases. With his expertise, Mr. Killeen plays a key role in advancing research projects.